Showing results (511-520 of 3,148) with videos related to
Sort By:
Pageof 315
Neuro-Oncology|December 26, 2023
Consensus framework for conducting phase I/II clinical trials for children, adolescents, and young adults with pediatric low-grade glioma: Guidelines established by the International Pediatric Low-Grade Glioma Coalition Clinical Trial Working GroupSabine Mueller, Jason Fangusaro, Arzu Onar Thomas, et al.Neuro-Oncology|December 23, 2023
Developing a computable phenotype for glioblastomaSandra Yan, Kaitlyn Melnick, Xing He, et al.Neuro-Oncology|December 23, 2023
Whole tumor analysis reveals early origin of the TERT promoter mutation and intercellular heterogeneity in TERT expressionChristina L Appin, Chibo Hong, Abigail K Suwala, et al.Neuro-Oncology|December 12, 2023
Visualizing cancer-originating acetate uptake through monocarboxylate transporter 1 in reactive astrocytes in the glioblastoma tumor microenvironmentDongwoo Kim, Hae Young Ko, Jee-In Chung, et al.Neuro-Oncology|March 19, 2024
Marizomib for patients with newly diagnosed glioblastoma: A randomized phase 3 trialPatrick Roth, Thierry Gorlia, Jaap C Reijneveld, et al.Neuro-Oncology|March 9, 2024
Executive summary of the American Radium Society appropriate use criteria for brain metastases in epidermal growth factor receptor mutated-mutated and ALK-fusion non-small cell lung cancerSeema Nagpal, Michael T Milano, Veronica L Chiang, et al.Neuro-Oncology|March 4, 2024
Integrating multi-modal imaging in radiation treatments for glioblastomaWilliam G Breen, Madhava P Aryal, Yue Cao, et al.Neuro-Oncology|January 23, 2024
Leveraging external control data in the design and analysis of neuro-oncology trials: Pearls and perilsMei-Yin C Polley, Daniel Schwartz, Theodore Karrison, et al.Neuro-Oncology|December 10, 2023
Defining interventions and metrics to improve diversity in CNS clinical trial participation: A SNO and RANO effortJoshua A Budhu, Ugonma N Chukwueke, Sadhana Jackson, et al.Neuro-Oncology|December 9, 2023
Cholesterol homeostasis confers glioma malignancy triggered by hnRNPA2B1-dependent regulation of SREBP2 and LDLRJuan Zhang, Bei Liu, Changwei Xu, et al.Pageof 315